Largest ever Parkinson’s research trial is starting now
Date
Research news
Date
The TOP HAT trial was halted in April. We’re delighted to announce that it is restarting.
Date
Parkinson’s UK has granted funding to projects aiming to advance our understanding of the causes and symptoms of Parkinson’s, as well as exploring new treatments.
Date
The results indicate that people in the study who received exenatide did not benefit compared to those who received placebo - suggesting that the drug does not slow down the progression of Parkinson’s.
Date
Parkinson’s UK led consortium is using big data to accelerate new treatment options, aiming to unlock a cure for Parkinson’s.
Date
The Beech Band, designed by Carl Beech, is a wearable device showing promising signs of being able to manage symptoms including speech issues, anxiety and gait.
Date
A small study shows that adaptive deep brain stimulation is better than the standard version at controlling movement symptoms day and night for people with Parkinson’s.
Date
We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.
Date
The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.
Date
We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson’s.
Date
We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson’s and to start exploring its potential benefits.